Does FOTEMUSTINE Cause Diffuse large b-cell lymphoma recurrent? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with FOTEMUSTINE. This represents 6.4% of all adverse event reports for FOTEMUSTINE.
17
Reports of Diffuse large b-cell lymphoma recurrent with FOTEMUSTINE
6.4%
of all FOTEMUSTINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From FOTEMUSTINE?
Of the 17 reports.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOTEMUSTINE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does FOTEMUSTINE Cause?
Off label use (66)
Disease progression (38)
Acute myeloid leukaemia (30)
Thrombocytopenia (29)
Mucosal inflammation (25)
Neutropenia (24)
Product use in unapproved indication (23)
Platelet count decreased (22)
Neutrophil count decreased (20)
Septic shock (20)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which FOTEMUSTINE Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
FOTEMUSTINE vs FRAMYCETIN
FOTEMUSTINE vs FREMANEZUMAB
FOTEMUSTINE vs FREMANEZUMAB-VFRM
FOTEMUSTINE vs FROVATRIPTAN
FOTEMUSTINE vs FRUCTOSE